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Summary 
A  high proportion of the CD34+CD38 -  cells in normal human marrow are defined as long- 
term culture-initiating cells  (LTC-IC) because they can proliferate and differentiate when co- 
cultured with cytokine-producing stromal feeder layers. In contrast, very few CD34+CD38 - 
cells  will divide in cytokine-containing methylcellulose and thus  are not classifiable  as direct 
colony-forming cells  (CFC),  although most can proliferate in serum-free liquid cultures con- 
taining certain soluble cytokines. Analysis of the effects of 16 cytokines on CD34+CD38 -  cells 
in the latter type of culture showed that Flt3-1igand  (FL), Steel factor (SF), and interleukin (IL)-3 
were both necessary and sufficient to obtain an N30-fold amplification of the input LTC-IC 
population within 10 d. As single factors, only FL and thrombopoietin (TPO) stimulated a net 
increase in LTC-IC within 10 d. Interestingly, a significantly increased proportion of the CFC 
produced from the  TPO-amplified LTC-IC were  erythroid.  Increases in the  number of di- 
rectly detectable CFC of >500-fold were also obtainable within 10 d in serum-free cultures of 
CD34+CD38 -  cells. However, this required the presence oflL-6 and/or granulocyte/colony- 
stimulating factor and/or nerve growth factor 13 in addition to FL, SF, and IL-3. Also, for this 
response, the most potent single-acting factor tested was IL-3, not FL. Identification of cyto- 
kine combinations that differentially stimulate primitive human hematopoietic cell self-renewal 
and lineage  determination should facihtate analysis  of the intracellular pathways that regulate 
these  decisions as well as the development of improved ex vivo expansion and gene transfer 
protocols. 
T 
he  most primitive  cells  of the  hematopoietic  system 
are characterized by an ability to  generate very large 
numbers of all known mature blood cell types. For exam- 
ple, in humans,  multilineage clonal blood cell populations 
of >1013 cells  derived  from putatively normal  stem cells 
have  been  reported  (1,  2).  However,  variability  in  the 
number of divisions that may precede terminal hematopoi- 
etic differentiation has been noted (3), and evidence of cells 
with extensive in vivo repopulating ability but at least par- 
tially restricted  differentiation potential has been reported 
(4, 5). Such findings have focused attention on the identifi- 
cation of other potentially unique  functional properties of 
human hematopoietic stem cells with self-sustaining multi- 
lineage  repopulating  abihty  that  might  serve  as  surrogate 
markers for the specific quantitation of these ceils.  One ap- 
proach has relied on the recognized ability of stromal cells 
to support the production in vitro for several weeks of clo- 
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nogenic  cells  (colony-forming cells  [CFC] 1)  from a  very 
small and phenotypically distinct subpopulation ofhemato- 
poietic  cells  that,  in  the  mouse,  have  not been separable 
from cells with long-term in vivo repopulating ability (6-8). 
In humans,  a subset of very primitive hematopoietic cells 
has  also  been  identified  by virtue  of its  similar ability to 
generate CFC progeny for at least 5 wk on suitable fibro- 
blast-containing  feeder layers of human  or murine  origin 
(9,  10).  During this process, some of the input long-term 
culture-initiating  cells  (LTC-IC)  thus  detected  also  un- 
dergo self-renewal divisions (11), although this does not re- 
sult in a net amplification of their numbers (12). 
1Abbreviations used in this paper: BFU, burst-forming  unit; CFC, colony- 
forming cell; Ep, erythropoietin; FL, Flt3-hgand; GEMM, granulocyte- 
erythroid-megakaryocyte-monocyte;  HC, hydrocortisone; HFN, Hank's 
Hepes-buffered  salt solution containing 2% FCS and 0.1% sodium azide; 
HLTM, long-term  culture medium; LTC-IC, long-term  ctflture-initiating 
cells; NGF-13, nerve growth factor 13; SF, Steel factor; TPO, thrombo- 
poietin. 
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Volume 183 June 1996 2551-2558 Recently  we  (11,  13)  and  others  (14,  15)  have  shown 
that  a  significant expansion of input  LTC-IC  populations 
can  be  obtained  in  vitro  when  various  cytokine  supple- 
ments are added and other alterations to the culture condi- 
tions are made. For example, in cultures initiated with single 
CD34+CD38 -  cells isolated fi'om normal adult human mar- 
row,  an  amplification  of  LTC-IC  of  30-fold  was  seen 
within 10 d with evidence of a further 2-fold expansion of this 
primitive progenitor population after an additional 2-3 wk 
(11).  In these cultures, the cells were maintained in the ab- 
sence  of stroma  in  a  serum-free  medium  containing  100 
ng/ml each ofFlt3-1igand (FL) and Steel factor (SF), 20 ng/ml 
each  of IL-3,  IL-6,  and  G-CSF,  and  5  ng/ml  of nerve 
growth  factor [3  (NGF-[3). This combination of cytokines 
was originally chosen on the basis of previous evidence that 
each component included might contribute to the prolifer- 
ation or maintenance of various types of primitive hemato- 
poietic cells (16--19)  or was produced by fibroblast feeders 
that had these properties (20,  and Coulombel, L., personal 
communication). The purpose of the studies described here 
was to identify the specific factors or combination(s) of fac- 
tors that can stimulate an expansion of LTC-IC in serum- 
free cultures initiated with CD34+CD38 -  cells. In addition, 
experiments were undertaken to determine how these fac- 
tor requirements might compare with those needed to max- 
imize CFC production from the same starting population. 
Materials and Methods 
Purification of Bone Marrow Cells.  Light-density cells  (<1.077 
g/cm  3) were isolated from previously frozen human  bone mar- 
row  obtained  from  cadaveric organ  donors  using  Ficoll-Paque 
(Pharmacia, Uppsala, Sweden). After washing these cells once in 
PBS  containing 2%  FCS  (StemCell Technologies,  Vancouver, 
BC,  Canada),  we  resuspended them  in  Hank's  Hepes-buffered 
salt solution containing 2%  FCS and 0.1%, sodium azide (HFN). 
The  cells were  then  incubated simultaneously at ~<107 cells/ml 
for 30 rain at 4~  with mAbs specific for CD34  (8G12-fluores- 
cein) and CD38  (Leu  17-PE) at 10 and 2.5 I,tg/ml, respectively. 
Cells were then washed once in HFN and once in HFN contain- 
ing 2 I~g/ml propidium iodide (PI, p-5264; Sigma Chemical Co., 
St. Louis, MO) before resuspension in Hank's Hepes-buffered .salt 
solution containing 2%  FCS for isolation of the CD34§  - 
population. Throughout  this staining procedure,  the  cells  were 
kept at 4~  Cells were sorted on a FACStar Plus  |  (Becton Dick- 
inson & Co., San Jose, CA) equipped with a 5-W argon laser and 
a 30-roW helium laser. Viable (PI-) cells with low-medium for- 
ward  scattering,  low side  scattering  characteristics,  and  a  CD34 + 
CD38- phenotype were collected in Eppendorf tubes containing 
serum-free lscove's medium. Positive and negative staining with 
antibodies specific for CD34 and CD38, respectively, was defined 
as the emission of  a level of fluorescence that exceeded (CD34) or 
did not exceed (CD38)  levels obtained by 99% of the cells from 
the same starting population when these were stained with con- 
trol lgG1 antibodies labeled with the corresponding fluorochrome. 
Colony Assays.  Cell  suspensions  to  be  assayed  for  erythro- 
poietic (CFU-E and burst-forming unit  [BFU-E]), granulopoi- 
etic (CFU-GM), and multilineage (CFU-granulocyte-erythroid- 
megakaryocyte-monocyte [GEMM]) CFC were plated at suitable 
concentrations  (to give <100  colonies per  1 rnl  culture)  in  Is- 
cove's medium containing 0.9% methylcellulose, 30%  FCS,  1% 
BSA, 10 -4 M 2-ME (Methocult H4430; StemCell Technologies) 
supplemented with 3 U/rnl of highly purified human erythropoi- 
etin (Ep; StemCell Technologies), 50 ng/ml of SF, and 20 ng/rnl 
each ofIL-3 (Sandoz International,  Basel, Switzerland), IL-6, G-CSF 
(Amgen, Thousand  Oaks,  CA), and GM-CSF  (Sandoz Interna- 
tional). SF and IL-6 were purified from the supernatants of COS 
cells transiently transfected in the Terry Fox Laboratory with cor- 
responding  human  cDNAs.  Methylcellulose cultures  were  ali- 
quotted in 1.1-ml volumes in 35-ram petri dishes and were then 
incubated at 37~  for 2-3 wk. At the end of this time, all colo- 
nies present were scored according to standard criteria. 
LTC-IC Assays.  For enumeration of LTC-IC, cells to be tested 
were placed in 35-mm tissue culture dishes that already contained 
a  feeder layer of irradiated (8,000  cGy) mouse  fibroblasts engi- 
neered to express 4 ng/ml of human  IL-3, 190 ng/ml of human 
G-CSF, and 4  ng/ml of human  SF (21),  plus 2.5  ml of human 
long-term  culture  medium  (HLTM).  HLTM  contains  12.5% 
horse serum,  12.5%  FCS, and  10 -4 M  2-ME (Myelocult; Stem- 
Cell Technologies), and  10 -e' M  hydrocortisone sodium hemi- 
succinate (HC;  Sigma Chemical Co.) added from a freshly pre- 
pared solution just before use. The cultures were then incubated 
for 6 wk at 37~  with weeHy replacement of half of the medium 
and removal of half of the nonadberent cells (21). After 6 wk, all 
of the remaining nonadherent cells from each assay culture were 
removed  and  added to  the  corresponding trypsinized adherent 
cells; the combined pool was then washed and assayed for CFC" as 
described above. The counts obtained were used to calculate the 
total yield ofCFC (BFU-E plus CFU-GM plus CFU-GEMM) at 
the end of 6  wk from each input inoculum tested as this value 
provides a relative, but nevertheless, quantitative measure of the 
number of LTC-IC initially present (9). 
Stroma-free Liquid Suspension Cultures.  For most  experiments, 
CD34+CD38 -  cells were  incubated in  I00 }zl of Iscove's me- 
dium supplemented with 20 ng/ml of BSA, 10 p,g/ml of human 
insulin, and 200 ~tg/ml of human transferrin (BSA insulin trans- 
ferrin; StemCell Technologies) plus 40 ~g/ml low demity lipopro- 
teins  (LDL;  Sigma Chemical  Co.).  10 -4  M  2-ME,  and  various 
growth factors plus or minus 10 -'~ M HC (as indicated) in round- 
bottomed wells of 96-well plates as previously described (11).  In 
one case (see Fig. 4) HLTM was used instead of the BSA insulin 
transferrin plus LDL serum substitute. The growth factors tested, 
either alone or in various combinations, were: FL and IL-7 (Im- 
munex Corp, Seattle, WA); SF and G-CSF (Amgen); IL-I (Bio- 
gen,  Cambridge,  MA),  IL-3  and  GM-CSF  (Sandoz  Interna- 
tional);  IL-11  and  IL-12  (Genetics Institute,  Cambridge, MA); 
IL-6, macrophage inflammatory protein lee (MIP-la), and NGF-I3 
(R&D Systems, Inc., Minneapolis, MN); leukemia inhibitory fac- 
tor (LIF) and Ep  (StemCell Technologies); TNF--a (Genentech, 
San  Francisco, CA); and thrombopoietin (TPO; ZymoGenetics, 
Seattle,  WA).  The  suspension  cultures  were  incubated  unper- 
turbed for 10 d at 37~  (except as indicated to the contrary), and 
then all cells in each type of culture were harvested and assayed 
separately for LTC-IC and/or CFC. 
Factorial Design Analysis Experiments.  A 25 factorial analysis de- 
sign was used to investigate the relative roles of six growth factors 
(two of which,  NGF-I3 and G-CSF, were considered as a fixed 
pair) in stimulating LTC-IC amplification. Each of the 32 possi- 
ble combinations of growth factors was tested in duplicate (each 
with a different source ofCD34+CD38 -  cells). The actual testing 
of each  of these sets  was  broken into  two subexperiments that 
were performed on different occasions (16 combinations each time) 
with the same cells.  Each of these subexperiments also included 
2552  Cytokine Effects on CD34*CD38-  Cells four replicate  cultures  containing all six factors at half the concen- 
trations  used in the other combinations. The LTC-IC expansion 
obtained with each growth factor or combination of growth fac- 
tors  in individual subexperiments was normalized as follows.  In 
each subexperiment,  the difference  between the logarithm (log) 
of each LTC-IC expansion measured and the mean of all the log 
LTC-IC  expansions  was  first  determined.  This  difference  was 
then divided by the standard  deviation of all the log LTC-IC ex- 
pansions.  This transformation allowed all the results from the four 
subexperiments to be analyzed as a single data set, using the Jass 
Software program (version 2.0; Joiner Associates, Madison, WI). 
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Results 
Multifactorial Analysis  of the  Relative  Contributions  of Six 
Growth Factors on LTC-IC Amplification.  In a first series of 
experiments  with  four  separately  isolated  CD34+CD38 - 
cell populations  (obtained from two marrow sources),  ali- 
quots of 200 CD34+CD38 -  cells were incubated for 10 d 
in 100-I.d liquid suspension cultures containing different com- 
binations  of six growth factors.  LTC-IC assays  were per- 
formed both on the initial CD34+CD38 -  cells and on the 
cells  harvested  from  the  10-d-old  cultures  to  determine 
the extent of the expansion  obtained with each condition. 
The  six  factors  evaluated  in  these  experiments  were  FL 
(100  ng/ml),  SF  (100  ng/ml),  IL-3  (20  ng/ml),  IL-6  (20 
ng/ml),  and  G-CSF  (20  ng/ml)  plus  NGF-[3  (5  ng/ml), 
since previous  experiments  had shown that  a  cocktail of 
all  of these factors would stimulate  a marked amplification 
of LTC-IC in cultures of single CD34+CD38 -  cells  (11). 
G-CSF and NGF-~ were evaluated together because initial 
results  of our own (data not shown)  and others  (Coulom- 
bel,  L.,  personal  communication)  had  already  suggested 
that  NGF-[3  would  not  stimulate  the  proliferation  of 
CD34+CD38 -  cells; this strategy also considerably reduced 
the magnitude of the experiments. 
A  measure  of the  LTC-IC content  of each of the  four 
input CD34+CD38 -  cell suspensions as well as of the cells 
harvested from each of the 80 different 10-d-old liquid sus- 
pension cultures (16 different combinations of growth fac- 
tors plus the four replicates in each of four subexperiments) 
was obtained by assessing the total CFC output for a fixed 
number  of original  CD34+CD38 -  cells.  The  validity  of 
this approach (rather than the use of limiting dilution anal- 
yses for quantitating  LTC-IC in each suspension)  is based 
on previous  data  showing that  the  numbers  and  types  of 
CFC  generated from individual  LTC-IC, although highly 
variable,  remain on average the same when freshly isolated 
and  cultured  LTC-IC  are  compared  (10,  11).  More  re- 
cently, these  relationships  have been  confirmed by formal 
limiting  dilution  analysis  experiments  (our  manuscript  in 
preparation),  although  as  noted  below,  one  circumstance 
where at least the type of CFC produced can be altered was 
also discovered in the present studies.  However, this change 
appeared to be uniquely related to the exposure of LTC-IC 
to  a  single  factor.  The  extent  of LTC-IC  amplification 
when all six growth factors were present was 24  +  5-fold 
(n  --  7,  Fig.  1).  This  magnitude  of LTC-IC expansion  is 
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Figure 1.  Variable  LTC-IC expansion from CD34+CD38  - cells incu- 
bated for 10 d in serum-free cultures containing different cytokine com- 
binations as shown. Flt3-1igand (r-'), Steel factor (S), IL-3 (3), IL-6 (6), 
G-CSF (G), and NGF-I3 (N). 168 +  48 CFC per 100 input cells were 
generated in the 6-wk LTC-IC assays of  the original CD34+CD38  - cells 
used to initiate the serum-free expansion cultures. (Bars)  Mean + SEM of 
the increases measured relative to the starting LTC-IC-derived CFC out- 
put value of the same experiment for data pooled from two to seven ex- 
periments. 
similar  to  that  measured  previously  when  single  CD34  + 
CD38-  cells were cultured in the same cocktail (11), sug- 
gesting that the extent of LTC-IC amplification obtained is 
relatively  independent  of  the  initial  concentration  of 
CD34+CD38 -  cells up to at least 200 per 100 p,1 (i.e., 2  ￿ 
103 CD34+CD38 -  cells per ml). 
The ability of the six factors tested (four individually and 
G-CSF and NGF-[3 as a pair)  to support the amplification 
of LTC-IC was then evaluated by muhiparameter analysis 
of variance  of the  normalized  data  from  all  four  experi- 
ments.  Such an analysis identifies  individual  or interactive 
effects as significant when the result of any particular factor 
or combination of factors is not explained by the variation 
accounted for by the normal probability distribution result- 
ing from the combined data from all groups (22). A  com- 
parison of the standard deviation of the four sets of replicate 
center points  (i.e.,  data from cultures containing all factors 
at  half the  concentration  used  in  all  other  groups)  estab- 
fished that the interexperimental variability was not signifi- 
cant (block effect in Fig. 2). Fig. 2 shows that the results of 
all of the possible combinations of growth factors tested, with 
the exception ofFL, SF, and IL-3 alone, lie within the vari- 
ance of the  normal probability distribution.  An indication 
of the unique and relative activities of these three factors to 
support the amplification of LTC-IC from CD34+CD38 - 
cells  can also be  seen  in  Fig.  1.  FL alone  was  able  to in- 
crease  the  number  of  LTC-IC  significantly  (P  <0.05) 
above the input value. SF and IL-3, alone, each maintained 
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Figure 2.  Linearized  normal probability distribution of the normalized 
effect of different combinations of cytokines  on LTC-IC expansion in 10-d 
serum-free cultures of CD34+CD38 -  cells. Significant  effects do not fall 
on the dashed line representing the normal probability distribution. In this 
plot, an effect is defined as the average  change in LTC-IC expansion that 
occurred  in  cultures  containing the  growth factor(s)  shown relative  to 
cultures not containing these factor(s).  Abbreviations are as indicated  in 
the legend to Fig. 1. 
LTC-IC numbers at a significantly higher level (P <0.05) 
than was seen when no factors were added,  although nei- 
ther SF nor IL-3 alone was able to stimulate an overall net 
increase in LTC-IC numbers. Interestingly, even in a com- 
pletely defined medium that contained insuhn but no other 
growth factors,  the  rate  of LTC-IC decline was relatively 
slow.  Accordingly, under these  conditions  many LTC-IC 
(7  +  1% of input values)  could still  be detected after  10 d 
(Fig.  1).  This is similar to results  obtained previously for a 
similar starting population of CD34+HLA-DR -+ cells incu- 
bated without growth factors but in the presence of serum 
(18).  Also evident in both Figs.  1 and 2  is the finding that 
the  minimum  combination  of FL plus  SF  plus  IL-3  was 
sufficient  to  obtain  the  greatest  LTC-IC  amplification 
observed  for  any  combination  of the  six  factors  tested. 
Moreover,  there were no significant effects attributable  to 
interactions  between  multiple  factors  (Fig.  2)  (22).  When 
the  concentration of each of the  six growth factors in the 
cocktail was reduced twofold,  the  extent  of LTC-IC am- 
phfication obtained was also reduced  (by 25%,  Fig.  1).  On 
the  other  hand,  repeated  daily  addition  of all  six  growth 
factors (in the same amounts as when added only at the be- 
ginning of the culture at full strength) resulted in a decrease 
in LTC-IC yields  (by 84%,  Fig.  1).  Taken together,  these 
results provide some indication of the existence of a dose- 
effect relationship for the stimulation of LTC-IC amplifica- 
tion by the combination of FL, SF, and IL-3. 
Effects  of D!fferent  Growth  Factors on  CFC  Production  by 
CD34+CD38 -  Cells.  In  earlier  experiments,  we  showed 
that LTC-IC maintenance in serum-containing cultures was 
not affected by several variations in the growth factor com- 
position of the medium that,  nevertheless,  had marked ef- 
fects on the number of CFC detectable after 5 wk (18).  It 
was,  therefore,  of interest  to determine  whether  LTC-IC 
amplification  and  the  production  of CFC  from  CD34 § 
CD38- cells would show a similar or different growth fac- 
tor dependence.  The CFC outputs measured for the vari- 
ous growth factor combinations tested in at least three ex- 
periments  are  shown  in  Fig.  3.  As  noted  previously  (11, 
23),  the  frequency  of CFC  in  the  initial  CD34+CD38 - 
populations was low (7  +  3%). Of the single factors tested, 
IL-3 was  the  most potent  stimulator  of CFC  production 
over the  10-d period  (~10-fold increase),  and neither  FL 
nor SF alone supported a net expansion of the CFC popu- 
lation.  On  the  other  hand,  when  combined,  these  three 
factors stimulated  an r  increase  in  CFC  numbers, 
and this was further increased  (another four- to eightfold) 
when  IL-6,  G-CSF,  NGF-~,  or all  three  of these  factors 
were also present. 
Ability  of Other Factors to Influence LTC-IC Amplification. 
A  final  set  of experiments  was  undertaken  to  determine 
whether  any  of a  number  of other  cytokines  previously 
shown  to  have  direct  effects  on  primitive  hematopoietic 
cells  could  further  enhance  LTC-IC  yields  from  CD34  + 
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Figure 3.  Variable  CFC expansion from CD34+CD38 -  cells incubated 
for 10 d in serum-free cultures containing different cytokines as shown. 7  -+ 
3  colonies per  100  CD34§  -  cells were generated  in  CFC  assays 
performed on the original  cells used to initiate  the serum-free expansion 
cultures.  (Bars)  Mean  -+  SEM of the  increases  measured relative  to  the 
starting CFC value in the same experiment (n/>3). 
2554  Cytokine Effects on CD34+CD38 -  Cells CD38-  cells  cultured  under serum-free  conditions  in the 
absence ofstroma. In addition, the effects of HC and HLTM 
(a medium containing both horse and fetal  calf serum)  on 
LTC-IC amplification were examined. Each condition was 
tested either alone or in combination with the original six- 
factor cocktail analyzed above. The results of these experi- 
ments are shown in Fig. 4.  Of the  10 additional  cytokines 
tested,  only TPO and IL-1 on their own (at 40 and  1,700 
U/ml,  respectively)  were  able  to  significantly  increase 
(P <0.05)  the number of LTC-IC detectable after  10 d in 
comparison to the numbers measured in the absence of any 
factor supplement.  Moreover, aside from FL (Fig.  1), TPO 
was also the  only factor that,  on its own, appeared able  to 
stimulate  LTC-IC  numbers  to  increase  above  the  input 
value  (P  <0.18;  see  also  Table  l).  In  addition,  none  of 
these  10 cytokines (including TPO), when added as a sup- 
plement (at the same concentration) to the original six-fac- 
tor combination, was able to further enhance the LTC-IC 
expansion already stimulated (Fig. 4). Many, (e.g., IL-12 at 
50 ng/ml,  IL-7 at  100 ng/m], MIP-lot at  100 ng/ml,  HC 
at  10 -6 M,  and TPO  at 40 U/m/)  in fact,  appeared  to be 
neutral in terms of having no modifying effect on LTC-IC 
output (like IL-6, G-CSF, and NGF-[~). Others clearly had 
a  significant  negative  effect  (e.g.,  TNF-(x  at  500  U/ml, 
P  <0.005; IL-11 at 100 ng/ml, P <0.05; LIF at 100 ng/ml, 
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Figure  4.  Effect  of 10 specific cytokines and HC on LTC-IC expan- 
sion from CD34+CD38  -  cells incubated for 10 d in serum-free cultures 
either alone (solid bars) or in combination with the six growth factor cock- 
tail analyzed in Fig. 1 (open bars). The effect of culture in HLTM alone 
was also tested. (Dotted lines) Fold change in numbers of LTC-IC detect- 
able in the absence of factor addition or in the presence of the six-factor 
combination alone (as indicated in Fig. 1). (*) Significant differences ver- 
sus no growth factor addition (TPO and IL-1, P <0.05) or versus the six- 
factor combination (TNF-ot,  P  <0.005;  LIF and IL-11,  P  <0.05;  Ep, 
P <0.10)  as determined by a two-tailed t test. (Bars) Mean +  SEM for 
data pooled from two to seven experiments. 
P <0.05,  and Ep at 3 U/ml,  P  <0.10).  TNF-ot in combi- 
nation with the six-factor combination was particularly po- 
tent in this regard, resulting in a decrease in LTC-IC num- 
bers  after  10  d  to  below  both  the  input  value  and  the 
number of LTC-IC detectable in cultures to which TNF-ot 
alone was added.  The dramatic  decline  in LTC-IC num- 
bers that occurred when TNF-cx was present together with 
the six-factor cocktail was not, however,  associated with a 
general loss  of CD34+CD38 -  cell viability.  In fact,  these 
conditions  stimulated  a large amphfication  (~350-fold)  in 
the total number of cells present after 10 d, which was also 
accompanied  by  the  generation  of a  large  population  of 
progenitors of small macrophage colonies (data not shown). 
On  evaluating  the  LTC-IC  produced  in  cultures  that 
contained  TPO  alone  or TPO  plus  the  six-growth factor 
cocktail, a change in the type of CFC present in the 6-wk- 
old LTC-IC assays  became apparent.  In both  of these  in- 
stances,  a  significantly  higher  proportion  of the  progeny 
CFC were erythroid progenitors (P <0.05)  in comparison 
to those generated  either from the initial  (CD34+CD38 -) 
LTC-IC, or from the LTC-IC produced in parallel cultures 
containing the six-factor cocktail but no TPO  (Fig.  5).  It is 
particularly interesting  to  note  that  although  this  effect  of 
TPO  was most pronounced for the  LTC-IC produced in 
the  presence  of TPO  alone,  a  significant  shift in favor of 
erythropoietic progenitors was also evident in the assays  of 
LTC-IC obtained from cultures where TPO was added to 
the six-factor cocktail, in which case there was no apparent 
effect of the  TPO  on LTC-IC amplification.  To examine 
whether  an  alteration  of LTC-IC differentiation  behavior 
had occurred in cultures containing any of the other cyto- 
kines  tested,  the  ratios  of CFU-GM  to  BFU-E  to  CFU- 
GEMM from all LTC-IC assays were compared. As is illus- 
trated by the examples shown in Table 1, these values were 
not found to be altered by any other factor or factor com- 
bination tested. 
Discussion 
This  study presents  a  comprehensive  analysis  of the  ef- 
fects of various cytokines on the generation within a  10-d 
period of two functionally distinguished but closely related 
populations  of primitive  human  hematopoietic  cells.  To 
minimize  potentially  confounding effects  of serum  or ac- 
cessory cells  (or their products),  the cultures were initiated 
at  a  low  cell  density with  a  highly purified  population  of 
CD34+CD38 -  ceils isolated from normal marrow and in- 
cubated in a completely defined medium. The results (sum- 
marized in Table  1)  show that the number of cells detect- 
able  as  LTC-IC  could  be  increased  in  10-d  cultures  that 
contained  ot~ly  FL  or  TPO,  indicating  unique  roles  for 
these factors either in triggering the activation of properties 
required for calls  to be detected as LTC-IC (within 6 wk) 
or for their self-renewal,  as has been recently confirmed for 
FL by  LTC-IC  pH]thymidine  suicide  experiments  (24). 
To our knowledge, the action of TPO on LTC-IC ampli- 
fication  has  not been  reported  previously.  It has  been  re- 
2555  Petzer et al. Table 1.  Effects  of Selected Culture  Conditions  on the LTC-IC and  CFC Detected in  lO-d-old  Serum-flee  Cultures Initiated with 200 
CD34+ CD38 -  Cells 
LTC-IC  LTC-IC--derived CFC 
Cytokine(s)  expansion  GM/B/GEMM  CFC expansion 
TPO  1.3 +  0.4  (5)*  86:12:2  ND 
FL  4.3 +  1.4  (3)  100:0:0  0.7 +  0.1 
SF  0.3 +  0.1  (2)  100:0:0  0.8 +  0.3 
IL-3  0.2 _-_ 0.1  (2)  99:1:0  9.6 +  2.5 
IL-6  0.01  •  0.01  (2)  98:2:0  0.5 +- 0.3 
G-CSF/NGF-~  0.07 •  0.07  (2)  100:0:0  0.05  +  0.05~ 
None  0.07  •  0.01  (6)  100:0:0  ND 
FL/SF/IL-3/IL-6/  24 •  5  (7)  97:2:1  670 +  300 
G-CSF/NGF-I3 
FL/SF/IL-3  49 +  20  (2)  97:3:0  76 •  25 
Input CD34+CD38 -  cells~  (7)  95:3:2 
(4) 
(4) 
(4) 
(4) 
(3) 
(4) 
(3) 
*Values shown represent the mean +  SEM (No. of experiments). 
$CFC expansion determined for G-CSF alone; i.e., without the addition of NGF-[3. 
~168 +- 48 CFC were measured in the 6-wk harvest of the LTC-IC assays  from 100 input CD34+CD38 - cells. The same input cells contained 7 + 
3 CFC per 100 cells. 
ported that  FL  in  combination  with  SF,  Pixy-123,  IL-3, 
GM-CSF, and Ep can enhance the plating efficiency of high- 
proliferative potential CFC (25-27); a possible role of FL in 
LTC-IC stimulation by marrow feeder layers has been in- 
ferred from  the  results  of antisense  Flt3  experiments  (28) 
and experiments in which FL has been added repeatedly to 
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Figure  5.  Effect of TPO  alone or together with a six-growth  factor 
cocktail on the relative proportions (ratio) of primitive erythroid (BFU-E) 
and granulopoietic progenitors (CFU-GM) produced after 6 wk from the 
LTC-IC generated in 10-d cultures containing these factors. Abbrevia- 
tions are as indicated in the legend to Fig. 1. Values shown are the mean 
•  SEM of ratios calculated from five separate experiments. (*) Significant 
difference (P <0.05) relative to the ratios measured both for the starting 
LTC-IC and the LTC-IC present after 10 d in cultures containing the 
six-factor cocktail only. 
LTC-IC  assay  cultures  (29).  More  recently,  we  reported 
that FL in combination with SF, IL-3, G-CSF, and NGF-[3 
could amplify LTC-IC in cultures of single CD34+CD38 - 
cells, although  the  specific role  of FL in  eliciting this  re- 
sponse was not examined in those studies (11). 
The results of the multifactorial analysis studies presented 
here show that within 10 d, FL alone can stimulate a signif- 
icant net increase in the number of LTC-IC present in cul- 
tures initiated with CD34+CD38 -  cells, and that the addi- 
tion  of SF and  IL-3 to  FL further  enhances  this increase. 
The multifactorial analysis also showed that there were no 
other significant interactions between any of the six factors 
tested in terms of their effects on LTC-IC amplification. In 
contrast, IL-3 was the only factor that alone was able to ex- 
pand the  CFC  population.  Nevertheless, the combination 
of FL, SF, and IL-3 showed evidence of strong synergy in 
stimulating the  production  of CFC;  this  could be  further 
enhanced  by  the  addition  of factors  like  G-CSF  or  IL-6 
that  had  no  effect on LTC-IC  amplification. These  latter 
findings are consistent with those reported for the effects of 
FL on primitive murine lymphomyeloid, myeloid, and lym- 
phoid CFC  (30). Taken together, these results extend pre- 
vious evidence of differences in the mechanisms that allow 
LTC-IC  function  to be  maintained  (with  or without  cell 
division) as compared with those that may stimulate loss of 
this function by the acquisition of properties that allow di- 
rect colony formation in semi-solid medium (18). 
Of the additional factors tested in combination with FL, 
SF,  IL-3,  IL-6,  G-CSF,  and  NGF-[3,  the  negative effect 
of TNF-c~ on LTC-IC numbers was the most striking, par- 
ticularly in  view  of the  rapid  cell  proliferation and  con- 
comitant  acquisition of restricted macrophage  differentia- 
2556  Cytokine Effects on CD34+CD38 -  Cells tion  potential  observed.  This  latter  response  could  reflect 
the  selective stimulation  of a  previously undefined  unique 
cell type also present  in  the  CD34+CD38 -  population,  as 
has been suggested for less purified populations responding 
to  SF,  GM-CSF,  and  TNF-~  (31).  Alternatively,  TNF-c~ 
may exert a  direct  deterministic  action  on  CD34+CD38 - 
LTC-IC  (or CFC)  when  these  are  simultaneously  stimu- 
lated  by  certain  other  growth  factors.  Single  cell  experi- 
ments will be required to resolve between these possibilities. 
Additionally,  the  observation  that  LTC-IC  generated  in 
the  presence  of TPO  subsequendy  showed  a  uniquely  in- 
creased  production  of erythropoietic  progenitors  was  also 
unanticipated.  Occasional  examples  of  apparendy  deter- 
ministic  effects  on  lineage  restriction  or  switching  have 
been previously reported in various immortalized hemato- 
poietic cell lines (32-34);  however, the ability of such lines 
to yield  further  information  about  mechanisms  of normal 
hematopoietic differentiation processes are questionable be- 
cause  of their  transformed  state.  The  apparent  ability  of 
TPO  to reprogram the  differentiation  behavior of primary 
LTC-IC,  as suggested  by the  present  findings,  would  cir- 
cumvent  this  type  of criticism.  This  experimental  model 
may therefore offer new opportunities  for future studies of 
how commitment events are normally regulated. 
Characterization  of culture  conditions  that allow human 
hematopoietic stem cell expansion is an important require- 
ment for the successful implementation of many clinical trans- 
plantation  and gene therapy protocols currently  under de- 
velopment. The present studies may represent a significant 
step towards the practical realization of such approaches by 
beginning to define the growth factor conditions that most 
effectively stimulate LTC-IC and CFC  amplification.  This 
information  is  also  likely  to  be  crucial  for  the  design  of 
larger  scale  systems  for  culturing  human  hematopoietic 
cells.  Finally, the present findings provide new distinctions 
between the biological effects of specific growth factors on 
a phenotypically defined (CD34 § CD38-)  human hemato- 
poietic cell target population.  Further analysis of the cellu- 
lar and  molecular basis  of these  different  responses  should 
provide  additional  clues  about  early events  in  hematopoi- 
eric cell differentiation and how they are activated by inter- 
actions with the extracellular milieu. 
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